|
FOR-DMD: DOUBLE-BLIND RANDOMIZED TRIAL TO OPTIMIZE STEROID REGIMEN IN DUCHENNE MD |
2U01NS061799-06 |
GRIGGS, ROBERT C |
NINDS |
2016 |
|
PLACEBO-CONTROLLED PHASE II TRIAL OF SGS742 (GABAB RECEPTOR ANTAGONIST) IN SUCCINIC SEMIALDEHYDE DEHYDROGENASE (SSADH) DEFICIENCY, A DISORDER |
3R01NS082286-04S1 |
GIBSON, K MICHAEL |
NINDS |
2016 |
|
INNOVATIVE ULTRASOUND TECHNOLOGY IN NEUROMUSCULAR DISEASE |
4K24NS060951-09 |
RUTKOVE, SEWARD B. |
NINDS |
2016 |
|
MRI BIOMARKERS OF PATIENTS WITH TUBEROUS SCLEROSIS COMPLEX AND AUTISM |
4R01NS079788-04 |
WARFIELD, SIMON K |
NINDS |
2016 |
|
PHASE II TRIAL OF SGS-742 IN SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY |
4R01NS082286-04 |
GIBSON, K MICHAEL |
NINDS |
2016 |
|
ADULT NEUROLOGICAL PHENOTYPES OF FRAGILE X GRAY ZONE EXPANSION |
4R01NS082416-04 |
HALL, DEBORAH A |
NINDS |
2016 |
|
EARLY BIOMARKERS OF AUTISM SPECTRUM DISORDERS IN INFANTS WITH TUBEROUS SCLEROSIS |
4U01NS082320-05 |
SAHIN, MUSTAFA |
NINDS |
2016 |
|
AN INDUCED PLURIPOTENT STEM CELL MODEL OF PCDH19-ASSOCIATED EPILEPSY |
5F30NS090780-02 |
DU, XI |
NINDS |
2016 |
|
GENES AND PATHWAYS UNDERLYING BRAIN OVERGROWTH AND FOCAL CORTICAL MALFORMATIONS |
5K08NS092898-02 |
MIRZAA, GHAYDA |
NINDS |
2016 |
|
MAGNETIC RESONANCE IMAGING AND SPECTROSCOPY BIOMARKERS FOR FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY |
5K23NS091379-02 |
LEUNG, DORIS G |
NINDS |
2016 |